Peptide leucine arginine

General Information


DRACP ID  DRACP04749

Peptide Name   Peptide leucine arginine

Sequence  MFTLKKSLLLLFFLGTISSSLCEQERDSDDEDQGEVTEQVVKRLVRGCWTKSYPPKPCFVRG

Sequence Length  62

UniProt ID  Q90WP7  P82110 

PubChem CID  Not available

Origin  Lithobates pipiens

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  2M3N 

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C316H503N83O95S4

Absent amino acids  AHN

Common amino acids  L

Mass  820142

Pl  6.46

Basic residues  9

Acidic residues  9

Hydrophobic residues  19

Net charge  0

Boman Index  -11512

Hydrophobicity  -30.97

Aliphatic Index  80

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  7115

Absorbance 280nm  116.64

Polar residues  18

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 14636071

Title  Not available

Doi Not available

Year  Not available

Literature 2

Pubmed ID 11099505

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.